Bobak R. Azamian, President/CEO and Board Chair at Tarsus Pharmaceuticals, Inc. (TARS), sold 9,000 shares at $16.80 ($151K) on 2023-05-10, disclosed to the SEC on 2023-05-12.
Scheduled sale ($151k) by President/CEO and Board Chair under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TARS | SELL | 2026-06-22 | $615K | — | Filing → |
| TARS | SELL | 2026-03-19 | $2.4M | — | Filing → |
| TARS | SELL | 2025-12-30 | $944K | — | Filing → |